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ABSTRACT
Olfactory reference syndrome (ORS) is a clinical condition that 
causes patients to be excessively anxious about emitting body 
odors that may be offensive for other people. This  causes heavy 
distress and depression, even leading to suicides.  The ORS is 
classifised under different categories. 
In this paper,  we  report a patient with ORS.  She  has  a 
preoccupation of foul body odor emanating from her anal region 
which we treated with escitalopram.  We also discuss,  within the 
framework of this case, the place of ORS in systems of clinical 
classified and in literature. 
Keywords: Olfactory reference syndrome, Classification, 
Treatment
ÖZET
Olfaktör referans sendromu (ORS), hastaların diğer insanlar için 
rahatsız edici olabilecek nitelikte kötü kokular yaydıkları konusunda 
oldukça endişeli olduğu klinik bir durumdur. Bu durum,  şiddetli 
stres ve depresyona sebep olup,   intihara bile yol açabilmektedir. 
Olfaktör referans sendromu, sınıflandırma sistemlerinde ve 
literatürde farklı kategoriler altında değerlendirilmektedir. 
Bu yazıda,  essitalopram ile tedavi edilen, anal bölgesinden 
kaynaklanan kötü kokular yaydığına dair preoküpasyonları olan 
bir ORS vakasını ve bu vaka çercevesinde  ORS’nu,  sınıflandırma 
sistemlerinde ve literatürde farklı kategoriler altında tartıştık. 
Anahtar kelimeler: Olfaktör referans sendromu, Sınıflandırma, 
Tedavi
Introduction
Olfactory reference syndrome (ORS) is a clinical condition 
that causes patients to be  anxious about emitting body odors 
that may be offensive for other people [1].
Patients with ORS react regretfully because  they feel 
shame for being, as they believe, the cause of the smell [1]. 
This situation causes heavy distress and depression, even 
suicides [2].
The International Classification of Diseases (ICD)-10 
referred to ORS in the section of delusional disorders. In 
The Diagnostic and Statistical Manual of Mental Disorders 
(DSM)-III’s 1980 North American edition, it was ranked 
among atypical somatomorphic disorders. The classification 
of ORS  was changed to somatic delusional disorder in the 
DSM-IV and it classified in the same way [3]. 
ORS  is treated with antipsychotics, antidepressants or 
combinations of both. [4]. In some studies, authors reported 
that the patients did not respond to antipsychotics, but 
responded to the selective serotonin reuptake inhibitors 
(SSRI). There are also case reports about patients that are 
treated with tricyclic antidepressants [5].
In this paper,  we  report a case with ORS which we 
treated with escitalopram. 
Case Report
Miss Y was a 22 year old university student living in a 
student hostel. The patient was admitted to the psychiatry 
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department for a gastroenterology consultation. She said 
that she had a foul body odor, the smell emanated from her 
anal region as a result of gas and faecal  incontinence. She 
emphasized that people reacted to  this foul odor. 
Her complaints started 2 months earlier. She said that 
one day when she entered the class; she felt a foul odor and 
someone from the classroom said “It smells so bad”. She 
added that since then she frequently perceived that foul odor 
resembling the odor of gas or faeces and started to think that 
the odor  might emanate from her body. There actually was 
no significant odour. She had started to wash  frequently, 
check her underwear for faecal stains, and change her 
clothing often, but had realized that a foul odor still emanated 
from her body. She added that the severity and the frequency 
of this foul odor had increased for the last month and that 
people recognized  this odor, looked at her strangely, and 
said something like “Smelling very bad”. She stated that she 
felt shame and embarrassment about her foul body odor and 
as a result of this, avoided more and more social interactions 
and started to miss days at school. She had become anxious 
and demoralized and started to suffer from insomnia. She 
decided to drop out the school. 
According to the psychiatric examination, her self care 
was adequate. Her clothing was compatible with her socio-
cultural situation and was avoiding eye contact from time 
to time. She was in cooperation with the physician. Her 
affect was very anxious and her mood was depressive. She 
cried continuously during the interview. Her thoughts were 
logically associated and goal directed. In the content of her 
thought there was a preoccupation with the idea that she 
smelled of faeces and gas because of a defect at her anal 
sphincter causing incontinence. Additionally,  she had 
referential ideas as other people recognized  the odor. There 
was no other thought disturbances except this preoccupation 
and related ideas. There was no hallucination or illusion. 
The test judgment, memory and concentration of the patient 
were adequate. Her insight was considered as poor to the 
illness.  
Her thoughts about the foul body odor and incontinence 
were considered as a preoccupation, not a delusion, as she 
said that she was not 100% certain about this idea on close 
questioning. Also she easily accepted the psychotropic 
medication and stopped to seek help from other departments 
like gastroenterology. 
There was no history of classic obsessions or 
compulsions or of any definite hallucinations or delusions. 
There was no history of substance abuse or of an underlying 
general medical disorder or another psychiatric disorder. 
There was no family history of any psychiatric disorder. She 
was defining her premorbid personality traits as sensitive, 
exacting, introvert and compatible in social relationships. 
The electroencephalography, computed tomography, 
B12, folate, complete blood count, urinalysis, and liver-
kidney-thyroid function test  were normal.
The patient was treated with escitalopram 10 mg daily. 
She showed a gradual reduction in her preoccupations 
about odors and depressive symptoms. As the patient’s 
symptoms (obsessions as intrusive thoughts about body 
odor, compulsions as repetitive cleansing and avoidance 
behaviors) were reminding the obsessive compulsive 
disorder (OCD) with poor insight according to DSM-IV 
[6], we decided to follow up the course of ORS symptoms 
with Yale Brown Obsessive-Compulsive Rating Scale like 
some researchers in the literature [7]. At the beginning of 
the treatment  the rating for her depressive symptoms on 
the Hamilton Depression Rating Scale was 35 and of her 
rating for  preoccupation and related behaviors on the Yale 
Brown Obsessive-Compulsive Rating Scale was 27. Four 
weeks later the scores fell to 20 and 16, eight weeks later 
fell to 7 and 8 respectively. The patient was treated with 
escitalopram for twelve months with remission. Then the 
pharmacotherapy was stopped. The follow up continued 
for one more year without medication. Symptoms remained 
significantly improved throughout this time.
Discussion
The mean age at ORS onset in the literature is the early or 
mid 20s [3],  but some researchers have found a mean onset 
of 15.6 ± 5.7 years [7]. The age onset of ORS symptoms in 
our patient  was  22 years which   was similar to the literature. 
Depression was often reported to be diagnosed as a 
comorbid disorder in patients with ORS [8,9]. Pryse-Philips 
[1], reported 36 ORS patients with severe depression 
symptoms which began after onset of ORS. In a cross-
sectional study, the authors reported that they determined 
depressive symptoms in nearly three quarters of their ORS 
sample which they considered to be secondary to ORS [7]. 
Smilar to the literature, our patient had severe depression 
symptoms which we considered to be primarily due to ORS. 
Although,  depression is reported to be the most common 
comorbid disorder in ORS, ORS may be comorbid with other 
disorders like schizophrenia, bipolar disorders, substance use 
disorders, social fobia, OCD, and body dismorfic disorder 
(BDD) [1,7]. In our patient, there was no other comorbid 
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psychiatric disorder except depression. 
Although,  patient’s beliefs about emiting foul body 
odor are often suggested to be delusional in ORS [9,10], 
some authors have noted that these beliefs are not always 
delusional [3,11,12]. In a recent research, twenty patients 
with ORS were systematically assessed using semi-structured 
measures and it was found to be that most patients (85%) 
had delusional beliefs, whereas 15% had poor or fair insight 
[7]. According to another research only 21% of 14 patients’ 
beliefs were delusional [12]. We assessed our patient’s 
beliefs as preoccupational, not delusional, with poor insight 
as she said that she was not 100% certain about this idea 
on close questioning. and easily accepted the psychotropic 
medication and stopped to seek help from other departments 
like gastroenterology. 
Pryse-Philips [1] indicated that almost all of the patients 
with ORS had lifetime ideas or delusions of reference 
involving misinterpreting other people’s comments or 
behaviors as confirmed by other authors [5,7,9]. Our patient 
had also referential thinking as other people looked at her 
strangely and said something like “It smells very bad” and 
realized the odor. 
It is reported that excessive repetitive behaviors often 
accompany with ORS symptoms [5,7,12]. The purpose 
of these behaviors is eliminating, checking, obtaining 
reassurance about, or masking the perceived foul body 
odor thought to be emanating from the patient’s body [7]. 
Furthermore, Stein et al.[5] indicate that symptoms related 
to body odor met the DSM-IV [6] criteria for obsessions 
( intrusive thoughts about body odor) and compulsions 
(repetitive cleansing behaviors) with poor insight. Also, 
avoidance behavior is typical in ORS [1]. In this context, 
our patient’s symptoms like preoccupations about her body 
odor and repetitive behaviors as washing up and changing 
her clothing   frequently and checking her underwear, were 
overlapping with OCD. Additionally, there are reported 
cases in the literature treated with SSRI treatment [5,13] and 
cognitive behavioral therapy [14] which are well known to 
be effective in OCD. Our patient was also treated with  SSRI, 
escitalopram, which improved the symptoms significantly. 
Stein et al. [5] suggest to make systematic studies with 
larger samples of patients with ORS  to determine whether 
ORS is best viewed as an OCD spectrum disorder or not. 
Consequently, ORS is a rare psychiatric disorder with a 
poor functional overcome when untreated, so it is important 
to diagnose these patients with ORS and know different 
treatment modalities. Its place in classification systems 
and literature is controversial. Further studies regarding 
symptoms, treatment and outcome are needed to fully 
determine this disease.
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